RichardCLauerMD

Oncology • Albuquerque, NM

Professor, Internal Medicine, University of New Mexico School of Medicine

Join to view full profile

Dr. Lauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lauer's full profile

Already have an account?

Office
1201 Camino De Salud Ne
Unm Cancer Center
Albuquerque, NM 87106
Phone+1 505-272-4946

Fax+1 505-272-8060
Is this information wrong?

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1988
Indiana University School of MedicineResidency, Internal Medicine, 1982 - 1985
New York Medical CollegeClass of 1982

Certifications & Licensure

IN State Medical License 1983 - 2025
NM State Medical License 2007 - 2025
GA State Medical License 1988 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014

Clinical Trials

Functional Electrical Stimulation (FES) Cycling for Children With Spinal Cord Injuries (SCI) Start of enrollment: 2004 Mar 01
Completed
Not Applicable
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
The Effect of Botox on Children With Cerebral Palsy Start of enrollment: 2007 Jan 01
Completed
Wavelet Analysis of Electromyography (EMG) in Cerebral Palsy Start of enrollment: 2007 Mar 01
Completed
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Start of enrollment: 2008 Sep 01
Terminated
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma Start of enrollment: 2010 Apr 01
Terminated
Phase 2
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Start of enrollment: 2011 Aug 09
Active, not recruiting
Phase 2
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2011 Jun 01
Withdrawn
Phase 2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Richard C Lauer, Marc Barry, Tracey L Smith, Andrew Maltez Thomas, Jin Wu, Ruofei Du, Ji-Hyun Lee, Arpit Rao, Andrey S Dobroff, Marco A Arap, Diana N Nunes, Israel T S...> ;Elife. 2023 Jan 16
2 citations
Improving Outpatient Infusion Clinic Wait Times at a Comprehensive Cancer Center.
Neda Hashemi-Sadraei, Shenthol Sasankan, Nick Crozier, Bernard Tawfik, Ronald Kittson, Janet Abernathy, Richard C. Lauer, Zoneddy Dayao> ;JCO Oncology Practice. 2021 Jun 17
Pharmacist-Driven Oral Oncolytic Medication Education and Consent.
Harmony Bowles, Bernard Tawfik, Janet Abernathy, Richard C. Lauer, Neda Hashemi, Zoneddy Dayao> ;JCO Oncology Practice. 2020 May 27
37 citations
Survival outcomes for advanced kidney cancer patients in the era of targeted therapies
Arpit Rao, Charles L. Wiggins, Richard C. Lauer> ;Annals of Translational Medicine. 2018 Aug 5
26 citations
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
Jonathan E. Rosenberg, Noah M. Hahn, Meredith M. Regan, Lillian Werner, Ajjai Alva, Saby George, Joel Picus, Robert S. Alter, Arjun Vasant Balar, Jean H. Hoffman-Censi...> ;British Journal of Cancer. 2018 May 1
6 citations
Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses
André Azevedo Reis Teixeira, Serena Marchiò, Emmanuel Dias-Neto, Diana N. Nunes, Israel Tojal da Silva, Bryce Chackerian, Marc Barry, Richard C. Lauer, Ricardo J. Gior...> ;EMBO Molecular Medicine. 2017 Oct 1
32 citations
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer
Fortunato Ferrara, Daniela I. Staquicini, Wouter H. P. Driessen, Sara D'Angelo, Andrey S. Dobroff, Marc Barry, Lesley Lomo, Fernanda I. Staquicini, Marina Cardó-Vila, ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2016 Nov 8
22 citations
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
Sumanta K. Pal, Arun Azad, Shailender Bhatia, Harry A. Drabkin, Brian A. Costello, John Sarantopoulos, Ravindran Kanesvaran, Richard C. Lauer, Alexander Starodub, Ralp...> ;Clinical Cancer Research. 2015 Aug 1
190 citations
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3
Ahmad Salameh, Alessandro K. Lee, Marina Cardó-Vila, Diana N. Nunes, Eleni Efstathiou, Fernanda I. Staquicini, Andrey S. Dobroff, Serena Marchiò, Nora M. Navone, Hitom...> ;Proceedings of the National Academy of Sciences of the United States of America. 2015 Jul 7
8 citations
Phase II Study of Sorafenib and Bortezomib for First-Line Treatment of Metastatic or Unresectable Renal Cell Carcinoma
Arpit Rao, Richard C. Lauer> ;The Oncologist. 2015 Apr 1
5 citations
Drug design strategies for the treatment of prostate cancer.
Richard C. Lauer, Sarah Friend, Cecilia Rietz, Renata Pasqualini, Wadih Arap> ;Expert Opinion on Drug Discovery. 2015 Jan 1
6 citations
Smooth muscle tumors of the appendix and colon: a collective review of the world literature.
G Tarasidis, B C Brown, Lee J. Skandalakis, G Mackay, Richard C. Lauer, Gray Sw, John E. Skandalakis> ;Journal of the Medical Association of Georgia. 1991 Dec 1
7 citations
Smooth muscle tumors of the rectum and anus: a collective review of the world literature.
G Tarasidis, B C Brown, Lee J. Skandalakis, G Mackay, Richard C. Lauer, Gray Sw, John E. Skandalakis> ;Journal of the Medical Association of Georgia. 1991 Dec 1
73 citations
Is prophylactic cranial irradiation indicated in small-cell lung cancer?
James Fleck, Lawrence H. Einhorn, Richard C. Lauer, Stephen Michael Schultz, Michael E. Miller> ;Journal of Clinical Oncology. 1990 Feb 1
3 citations
Etoposide and split-dose cisplatin in bronchogenic carcinoma.
Richard C. Lauer, W. B. Fisher, Kenneth Pennington, Rafat Ansari, Lawrence H. Einhorn, Patrick J. Loehrer> ;American Journal of Clinical Oncology. 1988 Dec 1
37 citations
KRAS2 oncogene overexpression in myelodysplastic syndrome with translocation 5;12.
Arun Srivastava, H. Scott Boswell, Nyla A. Heerema, Piruz Nahreini, Richard C. Lauer, Asok C. Antony, Ronald Hoffman, G Tricot> ;Cancer Genetics and Cytogenetics. 1988 Oct 1
191 citations
Salvage Therapy in Recurrent Germ Cell Cancer: Ifosfamide and Cisplatin plus Either Vinblastine or Etoposide
Patrick J. Loehrer, Richard C. Lauer, Bruce J. Roth, Stephen D. Williams, Lorrie A. Kalasinski, Lawrence H. Einhorn> ;Annals of Internal Medicine. 1988 Oct 1
7 citations
A variant t(X;15)(p11;q22) translocation in acute promyelocytic leukemia
Arun Srivastava, Nyla A. Heerema, Richard C. Lauer, Piruz Nahreini, H. Scott Boswell, Ronald Hoffman, Asok C. Antony> ;Cancer Genetics and Cytogenetics. 1987 Nov 1
Bone mineral density of the hip and knee in children with spinal cord injury.
Lauer, R.,Johnston, T. E.,Smith, B. T.,Mulcahey, M. J.,Betz, R. R.,Maurer, A. H.> ;J Spinal Cord Med. 2007 Sep 19
Join now to see all

Press Mentions

Staying Home for TreatmentSeptember 10th, 2019
Clinical Trial for Personalized Kidney Cancer VaccineApril 20th, 2015
Clinical Trial Offers Patient ‘Best Shot’ at Fighting Kidney CancerApril 20th, 2015